Optimising the management of cardiovascular comorbidities in NAFLD patients: its time to (re-) act!

With great interest, we have read the recent article by Simon et al,1 reporting a significant association between non-alcoholic fatty liver disease (NAFLD) and incident major adverse cardiovascular events. The authors found that patients with biopsy-proven NAFLD had a significantly higher incidence of ischaemic heart disease, stroke, congestive heart failure and death due to cardiovascular disease (CVD), when compared with matched controls. An excess in CVD morbidity and mortality was evident across all stages of NAFLD and increased with worsening disease severity. The authors are to be congratulated for conducting such a large population-based retrospective cohort study including data of more than 10 000 patients with histologically confirmed NAFLD free of pre-existing CVD at baseline followed over a very long observation period of 13.6 years. The findings are in line with several recently published studies and provide further evidence that NAFLD might be an independent risk factor for...
Source: Gut - Category: Gastroenterology Authors: Tags: Gut PostScript Source Type: research